In a formal letter to Dr Rajeev Singh Raghuvanshi, DCGI and the Member Secretary of the DTAB, the association expressed stiff opposition to the proposal discussed during the board's 93rd meeting. The contentious recommendation seeks to redefine the qualifications of the ‘competent person’ required to manage wholesale drug premises under Forms 20B and 21B, potentially opening the role to science graduates. Under the new proposal, the eligibility for a competent person would include registered pharmacists or science degree graduates (BSc) with at least two years of experience in dealing with drugs and a six-month online certificate course recognized by authorities such as the PCI, NIPER, or the Skill Development Council. This is a significant shift from the previous stance discussed in August 2024, where it was suggested that only those with a pharmacy background, such as D.Pharm, B.Pharm, or Pharm D, be eligible. The DTAB argues that the move is necessary to strengthen the supply chain and ensure drug quality, safety, and efficacy in a modern, complex pharmaceutical landscape.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.